Literature DB >> 28842141

Defibrotide Use in Vincristine-induced Hepatic Sinusoidal Obstruction Syndrome.

Catherine Tang1, Julian Lindsay2, Anthony Gill3, Ian Kerridge2.   

Abstract

Entities:  

Keywords:  Defibrotide; Diffuse Large B cell Lymphoma; Hepatotoxicity; Veno-occlusive disease; Vincristine

Mesh：

Substances：

Year:  2017        PMID： 28842141     DOI： 10.1016/j.clml.2017.06.032

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  2 in total

1.  Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program.

Authors:  Nancy A Kernan; Paul G Richardson; Angela R Smith; Brandon M Triplett; Joseph H Antin; Leslie Lehmann; Yoav Messinger; Wei Liang; Robin Hume; William Tappe; Robert J Soiffer; Stephan A Grupp
Journal:  Pediatr Blood Cancer       Date:  2018-06-06       Impact factor: 3.167

2.  Hepatic Sinusoidal Obstruction Syndrome in a Patient With Multiple Myeloma Treated With CyBorD.

Authors:  Tooba Tariq; John Dawdy; Sachin Goyal; Bashar Mohamad; Manmeet Singh; Milton Mutchnick; Murray Ehrinpreis
Journal:  ACG Case Rep J       Date:  2019-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.